Aj. Larner, NEURITE GROWTH-INHIBITORY PROPERTIES OF AMYLOID BETA-PEPTIDES IN-VITRO - A-BETA-25-35, BUT NOT A-BETA-1-40, IS INHIBITORY, Neuroscience research communications, 20(3), 1997, pp. 147-155
The effects of freshly-solubilized synthetic amyloid beta-peptides on
the growth of neurites from high density cultures of embryonic chick d
orsal root ganglia and retinal pieces over periods of 24 to 48 hours w
ere examined. The undecapeptide beta 25-35, the presumed neurotoxic mo
iety of beta 1-40, was found to inhibit neurite outgrowth, whereas bet
a 1-40 and beta 1-28 were without effect. The growth-inhibitory effect
of beta 25-35 was apparent at a concentration of 10 ng/ml and showed
concentration dependence. The inhibitory effect was reversible, since
dorsal root ganglia grown initially in beta 25-35-supplemented medium
showed more extensive neurite outgrowth when transferred to normal gro
wth medium after 24 hours than dorsal root ganglia maintained in fresh
ly-made beta 25-35-supplemented medium throughout. It is concluded tha
t beta 25-35 has neurite growth-inhibitory properties in vitro not sha
red by beta 1-40 or beta 1-28. The differences in peptide behaviour ma
y be related to aggregation state. These findings may have implication
s for understanding plaque morphology in normal ageing and Alzheimer's
disease, since N-terminally truncated amyloid beta-peptides are prefe
rentially localized in the diffuse plaques which lack a surrounding ne
uritic reaction; this may also indicate a physiological neurite growth
-inhibitory activity for N-terminally truncated amyloid beta-peptides.